According to available market research, the global market for wearable bioelectronics for pain management is estimated to be around USD 2.2 billion in 2021 and is expected to reach USD 3.3 billion by 2026. This market is experiencing significant growth driven by factors like increasing chronic pain prevalence, technological advancements, and rising awareness of non-drug pain management options. We are actively seeking distribution and marketing partners for RecoveryRx - a class II, US FDA cleared drug-free, non-invasive device for pain. https://lnkd.in/eQzhyMfw Contact us at info@bielcorp.com or 866-757-2284.